Stay updated on JNJ-67856633 in NHL & CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.

Latest updates to the JNJ-67856633 in NHL & CLL Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAccess to the study record has changed from a detailed page to a 403 Forbidden error page, with minimal navigation and a revision note, indicating the content is no longer publicly viewable. This replaces the full study details, locations, and related information that were previously visible.SummaryDifference17%

- Check55 days agoChange DetectedThe page's revision tag has been updated to v3.6.6, replacing the previous v3.6.5, indicating a minor build update.SummaryDifference0.0%

- Check63 days agoChange DetectedA funding line stating '2018 ( U.S. NIH Grant/Contract )' was added to the study record. This clarifies the source of NIH support for the study and enhances transparency of the trial's financial backing.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated to v3.6.5, replacing the prior v3.6.4. This update indicates a newer page version but does not alter substantive study data or eligibility information.SummaryDifference0.0%

Stay in the know with updates to JNJ-67856633 in NHL & CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.